Primecujete razliku od videa😉🥰🍀

Omooo Silva is wayyÿÿyyyyyyyy past his primec

★パテサロデイリー【昨日の英語知財ニュース】 2026年6月12日号 ・XocketsがNVIDIA・Microsoft・AmazonのAIチップインフラ特許侵害でITC調査開始 ・Warner MusicがAI著作権保護・収益化プラットフォームSureelを買収 ・LG Energy SolutionがSunwoda・Tulip Innovationとの電池特許訴訟を和解で解決 ・NFL選手Fernando MendozaがLucasfilmと衝突しかねない「Nandolorian」商標を出願 ・ベトナムがWindowsおよびMicrosoft Officeの海賊版ソフトをめぐる初の刑事訴追 ・GSKが特許崖に備えNuvalentを106億ドルで買収へ ・インドPuri Jagannath寺院が聖地関連名称の商標保護を取得 ・EFFが著作権局の行政府移管法案を「惨禍」と批判 ・Nokiaが2026年の特許ライセンスで強力な進展、IoT向け新戦略を展開 ・InterDigitalがAmazonと特許ライセンス契約を締結 ・NeuroSenseが韓国でALS治療薬PrimeCの特許を取得 ・Medicennaが脳がん・免疫療法向けSuperkineプラットフォームで米国特許を複数取得 ・Lam ResearchとPSKが半導体検査方法特許をめぐって争う ・USPTOがテレワーク廃止で連邦労働法に違反したとの仲裁裁定 ・Ferringに対する2500万ドルの特許判決をデラウェア州裁判所が支持 ・FanDuelがアプリ特許侵害訴訟に直面 ・Tencent独占著作権の放棄が中国コンテンツ企業に変革を迫る ・インドDelhi高裁がMakeMyTripに類似した「MakeMyIndiaTrip」の使用を禁止 ・YahooがAd .comをドメイン名商標窃取の詐称で提訴 ・ワールドカップ商標規制にカナダのパブ・レストランが注意を払う ・SACEMがフランスのAI著作権法制化への求めを再び表明 ・日本政府がコンテンツ産業の海外著作権侵害訴訟を支援へ ・Teslaがマトリクスヘッドライトのより安価な製造方法の特許を出願 ・米国議会議員が敵対的中国企業を米国特許取得から排除する法案を提出 note.com/patesalo/n/n8af88f5…

$NRSN NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS More Info: pryzm.ozmosi.com/product/281…

#NeuroSense #Granted #South #Korean #Patent #Covering #PrimeC #Composition for #ALS tinyurl.com/2s3bzy26 $NRSN @NeurosenseT

パテサロデイリー ★パテサロデイリー【昨日の英語知財ニュース】 2026年6月10日号 ・米国下院が著作権局を行政府に移管する法案を可決 ・Levi StraussがオーストラリアのGlobeをタブ商標の模倣で再提訴 ・JumioがFaceTecとの4件すべてのIPR特許審判に敗訴 ・DeepIPがPatentMakerを買収し欧州のAI特許市場に参入 ・AlteogenがALT-B4の欧州特許承認を取得、皮下投与プラットフォームの世界展開を強化 ・Von DutchがSheinを商標侵害で提訴 ・QualcommがコアデザインをめぐるRedstoneの特許訴訟を再び起こされる ・Appleがスクリーンスライドと音声認識の特許訴訟でそれぞれ勝訴 ・Philip MorrisがBATとのタバコフリーポーチ特許訴訟に勝訴 ・KatapultがFlexshopper・ReadySettとの特許訴訟を和解で解決 ・Udiosの「機密」データを封印した命令が裁判官によって取り消される ・ITCがAmazonのスマートデバイスに対してAI特許侵害調査を開始 ・IncyteがJakafi特許崖に備えて出血性疾患治療薬を20億ドルで取得 ・NeuroSenseが日本でPrimeCの特許を取得、2042年まで保護期間を延長 ・LinkConnect InnovationsがNokia・Alcatel-Lucentの特許ポートフォリオで発足 ・Volt CarbonがGRAPHFLAKEとGRAFLAKEの米国商標登録を取得 ・Shoalsが太陽光発電技術の特許を競合Voltageから守る ・「Hot Girls Read」商標がBookTokコミュニティで引き続き論争に ・中国・ブラジルが特許審査にAIを活用しつつ人間の監督を維持 ・日本知財高裁がSubaruのマニュアルを根拠に自動運転特許の補正を却下 ・ToyotaがEV向けフェイクマニュアルトランスミッション技術の特許を継続出願 ・インドDelhi高裁がGOLDIEEブランドを騙る詐欺サイトのテイクダウンを命じる ・韓国政府がソウルでコンテンツ著作権侵害取締り合同会議を開催 ・中国の小説ライブ配信が著作権論争を引き起こす note.com/patesalo/n/na7098e2…

$NRSN NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition More Info: pryzm.ozmosi.com/product/281…

#NeuroSense #Therapeutics Receives #Japanese #Patent #Grant for #PrimeC #Novel #Composition tinyurl.com/25bz5yd4 @NeurosenseT $NRSN

$NRSN — Very Bullish 🚀 🏷️ $0.771 NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition Bull Case: The Japanese patent grant through 2042 significantly strengthens NeuroSense's global intellectual property estate for PrimeC in a key pharmaceutical market, following recent patents in the U.S., Australia, and Brazil. PrimeC has received FDA clearance and is preparing for a pivotal Phase 3 clinical trial (PARAGON) for ALS, indicating significant progress towards potential commercialization. Compelling Phase 2b data, including consistent clinical, biomarker, and survival benefits, provides a strong foundation and reduces risk for the upcoming Phase 3 trial. Bear Case: − Despite positive earlier data, Phase 3 clinical trials are inherently risky, expensive, and can fail, which would negatively impact the stock. − As a penny stock, NRSN may experience high volatility, and initial gains from this news could be subject to rapid profit-taking. This is a highly bullish catalyst for NRSN, providing substantial intellectual property protection in a major market for its lead ALS drug, PrimeC, as it progresses towards a pivotal Phase 3 trial. Given the official nature of the release, the critical stage of the drug development, and the timing of the news pre-market, active day traders should anticipate significant upward momentum and increased volume at market open. This patent grant de-risks the commercialization pathway for a promising candidate in a hot sector, making it an attractive trade. #pennystocks #daytrading Not financial advice. DYOR.

Ko bojo obesili izraelsko zastavo, ko bo janez rekel, moj dober prijatelj, se spomnite na tole, ko bo Logar gobcal, Svete je bil, ko bo Vrtovec gonil gobec, ko bo Lotrič gonil gobec. pvm. Primec in ostala drhal, Za otroke gre.

PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #ALS over 18 months of treatment. ja.ma/3RpbO2d

Board Member Merit Cudkowicz is the lead author of a study testing a new therapy for #ALS called PrimeC. It lowered levels of the protein ferritin and microRNA molecules associated with ALS, reducing symptoms and the risk of ALS-related complications. ow.ly/SsrP50Z1hjE

But not every member did this and could do this. Why ot7ing everything? Lmao. And why cant u just mention Jimin? And dont joke about Jimin’s chronic back pain.theyre in their primec, yes but clearly not all the members have been performing like Jimin.

🎙️ Ep. 723 NiceHash | The Truth about BTC Mining in 2026 (feat. Filip Primec) — — — For episode 723 of the BlockHash Podcast, host Brandon Zemp is joined by Filip Primec, Director of @NiceHashMining. With a robust background in law, he has been a member of the Slovenian Bar Organization since 2012 and previously served as Head of the Legal Department at NiceHash since 2017. Filip is a legal expert in IT, blockchain, and online services. A trained lawyer turned Bitcoin enthusiast, he began his crypto journey with NiceHash in 2017. Over the years, he has handled everything from regulatory discussions and tax issues to building AML frameworks and responding to security incidents. Having seen the industry evolve from its “wild west” phase to today’s regulated markets, he remains committed to its continued growth. 🔗 Spotify: tinyurl.com/y3w7chbw 🔗 Apple Podcasts: tinyurl.com/ymjbust5 🔗 Amazon Music: tinyurl.com/4jkscad9 🔗 YouTube: tinyurl.com/4erv8vev ⏳ Timestamps: (0:00) Introduction (3:11) Who is Filip Primec? (7:07) How Bitcoin mining has changed over time (10:58) What is EasyMining and the features for users? (12:35) How has NiceHash evolved with the markets? (16:20) How do regulations affect the crypto mining sector? (22:20) Does AI have an impact on crypto mining? (25:58) NiceHash roadmap (27:36) NiceHash website & socials #BlockHashPodcast #nicehash #bitcoin #mining #btcmining #podcast

🎙️ Ep. 723 NiceHash | The Truth about BTC Mining in 2026 (feat. Filip Primec) — — — For episode 723 of the BlockHash Podcast, host Brandon Zemp is joined by Filip Primec, Director of @NiceHashMining. With a robust background in law, he has been a member of the Slovenian Bar Organization since 2012 and previously served as Head of the Legal Department at NiceHash since 2017. Filip is a legal expert in IT, blockchain, and online services. A trained lawyer turned Bitcoin enthusiast, he began his crypto journey with NiceHash in 2017. Over the years, he has handled everything from regulatory discussions and tax issues to building AML frameworks and responding to security incidents. Having seen the industry evolve from its “wild west” phase to today’s regulated markets, he remains committed to its continued growth. 🔗 Spotify: tinyurl.com/y3w7chbw 🔗 Apple Podcasts: tinyurl.com/ymjbust5 🔗 Amazon Music: tinyurl.com/4jkscad9 🔗 YouTube: tinyurl.com/4erv8vev ⏳ Timestamps: (0:00) Introduction (3:11) Who is Filip Primec? (7:07) How Bitcoin mining has changed over time (10:58) What is EasyMining and the features for users? (12:35) How has NiceHash evolved with the markets? (16:20) How do regulations affect the crypto mining sector? (22:20) Does AI have an impact on crypto mining? (25:58) NiceHash roadmap (27:36) NiceHash website & socials #BlockHashPodcast #nicehash #bitcoin #mining #btcmining #podcast

🤣🤣🤣 To se boste borili sami s sabo in spravljali v arest? Primec dobi ministrstvo v MB, pa Rončević postavi še kakšno bajto brez gradbenega dovoljenja. 😆

pe tine nici un te primesc acolo. Am auzit ca nu primec femei 😂

PrimeC demonstrated comparable safety to placebo and showed slowed functional decline, reduced ALS-related complications, and modulation of iron-regulatory and microRNA biomarkers in adults with #ALS over 18 months of treatment. ja.ma/4bIp6Pb